Detalhe da pesquisa
1.
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.
J Natl Compr Canc Netw
; 20(9): 972-980, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075393
2.
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(2): 191-226, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545690
3.
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
J Natl Compr Canc Netw
; 17(8): 896-909, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390583
4.
National Cancer Database Report of Lymphadenectomy Trends in Endometrial Cancer.
Int J Gynecol Cancer
; 27(7): 1408-1415, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28525495
5.
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.
Nat Commun
; 14(1): 4513, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37500647
6.
Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary location.
J Natl Compr Canc Netw
; 10(9): 1076-80, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22956806
7.
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.
Sci Signal
; 13(619)2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071169
8.
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).
Clin Cancer Res
; 26(11): 2477-2486, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31992589
9.
Endometrial Cancer Treatment: Long-Term Engagement Strategies.
Int J Radiat Oncol Biol Phys
; 118(2): 321, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38220253
10.